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EFFECT OF ORALLY ADMINISTERED ANTIBACTERIAL AGENTS
ON TITRATABLE ACIDITY OF HUMAN SEBUM*
JOHN S. STRAUSS, M.D. AND PETER E. POCHI, M.D.
Human surface lipid causes an inflammatory
reaction in the skin when injected intradermally
(1). Histologically, the inflammation is lympho-
cytic in type and resembles the early inflamma-
tory changes observed after follicular rupture in
acne vulgaris. The free fatty acid component of
surface lipid is chiefly responsible for inducing
this response, and it is likely that free fatty
acids within the pilosebaceous follicle are impor-
tant for the development of inflammatory acne
lesions. Reduction in the concentration of free
fatty acids would be expected, then, to reduce
the severity of the disease.
In a previous paper it was shown that the
oral administration of tetracycline decreases
the titratable acidity of surface lipid from the
skin surface in both normal individuals and
those with acne (2). This reduction in free
acidity was not accompanied by any change in
the concentration of total fatty acids or in the
rate of sebum secretion. In the subjects who
had acne, the reduction in the free acids was
accompanied by clinical improvement. The
present studies were undertaken to determine
whether other antibacterial compounds share
with tetracycline this capacity to reduce the con-
centration of free acidity of skin surface lipid.
Data will be presented on the effect of the oral
administration of penicillin, erythromycin, de-
methylchlortetracycline, sulfisoxazole and sulfa-
dimethoxine on the titratable acidity of surface
lipid.
MATERIAL AND METHODS
Fifteen normal adult male volunteerst without
acne, 20—40 years old, comprised the study group.
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There were a total of 28 drug-treatment periods
such that several subjects received more than one
drug trial. The period of drug administration
lasted for 9 weeks except that sulfisoxazole was
administered for 18 to 21 weeks. Where individuals
received more than one drug trial, a recovery
period of approximately 9 weeks was allowed
from the effect of the previous drug.
The samples of surface lipid (herein referred
to as sebum), were obtained from the center of
the forehead without any prior treatment of the
collection site. Glass cups with an internal area
of 10 cm' were held firmly in place against the
skin and 5 ml of ethyl ether were introduced into
the cup. After 30 seconds, the solvent was aspi-
rated and used for subsequent analyses.
Half of the sample was used for the gravi-
metric determination of the amount of ether-
extractable material in the specimen. The rest of
the sample was titrated by a micropotentiometric
procedure described by us elsewhere using 0.01 N
ethanolic potassium hydroxide as the titrant (3).
The values for titratable acidity are expressed
as microequivalents of acid per milligram of se-
bum. Collections were made twice weekly, but for
tabular purposes all the results obtained in each
treatment trial have been grouped into successive
three-week periods. Thus, the average value for
each three-week period of drug administration
represents approximately six determinations. The
mean of all individual values during the entire
treatment period was also determined for each
subject.
RESULTS
The data for titratable acidity during treat-
ment with the various antibacterial agents is
presented in Tables I—V and summarized in
Table VI. For reference purposes, the previ-
ously published data for tetracycline is in-
cluded in Table VI (2).
Penicillin.—Potassium phenoxymethyl peni-
cillin was administered to 7 subjects in 10 drug
trials in dosages of 600,000, 1,200,000 and
2,400,000 units per day (Table I). No decrease
in the titratable acidity of sebum was seen with
dosages of 600,000 and 1,200,000 units per day.
With 2,400,000 units of penicillin daily, a defi-
nite decrease in free acidity was observed in sub-
ject 5. This same individual had previously not
shown an effect from the lower dose of 1,200,000
rectional Institution, Walpole, Massachusetts,
Palmer C. Scafati, Superintendent.
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TABLE I
Titratable acidity of sebum during the
administration of potassium
phenoxvmethyl penicillin
Mean titratable acidity
(pEg/mg of sebum)
TABLE II
Titratable acidity of sebum during the
administration of erythromycin estolate,
1 gm daily
Treatment periods
Control
period
Mean titratable acidity
(pEajmg of sebum)
All
1st 3 2nd 3 3rd 3 treat-
weeks weeks weeks ment
values
Subject
A) 600,000 units!
day
Mean
1
2
3
Treatment periods
.54
• 53
• 51
lst3 2nd3
weeks weeks
Subject
6
8
9
10
Mean
.65
59
.59
.45
.61
55
.62
67
.53
.58
.62
.55
Control
period
.65
.69
.67
.57
.65
.53 .61 .54
3rd 3
weeks
.42
.60
.49
.36
.47
.61
.48
.59
.52
.42
.50
.58
All
treat-
ment
values
.48
.58
.49
.39
49
.49
.52
.46
.39
.47
TABLE III
Titratable acidity of sebum during the
administration of demethylehiortetracy-
dine hydrochloride, 600 mg daily
B) 1,200,000 units!
day
4
5
6
7
Mean
.86
.74
.43
.31
.59
.90
.78
.40
.27
.59
.91
.77
.43
.29
.60
1.09
.77
.59
.37
.71
.98
.77
.50
.31
.64
C) 2,400,000 units!
day
4
5
7
Mean
1.03
.86
.37
.75
1.04
.83
.46
.78
.96
.69
.44
.70
.92
.57
.35
.61
.97
.70
.43
.70
Mean titratable acidity
(pEg/mg of sebum)
Treatment periods
lstS 2nd3 3rd3
weeks weeks weeks
Subject
2
4
5
11
Mean
Control
period
.47
.91
.80
.80
.75
.40
.66
.54
.58
.55
All
treat-
ment
values
.37
.40
.37
.50
.41
.27
.37
.22
.55
.35
.50
.39
.33
.39
.40
* This value in all tables has been calculated
from all treatment values and not from the means
for the three treatment period
units per day. The other two subjects adminis-
tered 2,400,000 units daily failed to demonstrate
a reduction in titratable acidity.
Erythromycin. Four subjects received eryth-
romycin estolate (Ilosone®) per day (Table
II). Three of the four subjects (nos. 6, 9 and
10) showed a decided decrease in titratable
acidity.
Demethylchlortetracycline. Four subjects were
administered demethyichlortetracycline hydro-
chloride (Declomycin®) in a dose of 600 mg
Supplied by E. Linn Jones, M.D., Lilly Re-
search Laboratories, Indianapolis, Indiana.
Supplied by Virgil A. Place, M.D., Lederle
Laboratories, Pearl River, New York.
per day (Table III). There was a resultant re-
duction in free acidity of the surface sebum in
three subjects (nos. 4, 5 and 11).
Sulfisoxazole. Seven subjects received sulfisox-
azole (Gantrisin®) II (Table IV). In each in-
stance they were given 2 gm daily for either
3 or 4 consecutive three-week periods. The dose
was then increased to 4 gm per day, and this
latter dose of medication was continued for an
additional 9 weeks. There was no rest period
in between the two dose schedules. In subject 3,
II Supplied by Erwin N. Whitman, M.D., Hoff-
mann-LaRoche, Inc., Nutley, New Jersey.
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TABLE IV
Titratable acidity of sebum during the administration of sulfisoxazole
Subject
Mean titratable acidity (jsEq/mg of sebum)
Control period
Treatment periods
2 gm/day 4 gm/day
1st
3 weeks
2nd
3 weeks
3rd
3 weeks
4th
3 weeks
1st
3 weeks
2nd
3 weeks
3rd
3 weeks
All
treatment
values
1
2
3
12
13
14
15
Mean
.47
.47
.49
.66
.58
.38
.36
.49
.47
.34
.34
.61
.60
.42
.26
.43
.36
.51
.43
.69
.56
.41
.36
.47
.60
.56
.42
.66
.47
.48
.29
.50
.61
—
—
—
—
.48
—
—
.57
.53
.45
.67
.38
.44
.39
.49
.57
.44
.35
.72
.42
.48
.46
.49
.69
.62
.45
.76
.42
.46
.57
.57
.54
.50
.40
.68
.48
.45
.38
.49
.Subject
Mean titratable acidity
(,Eojmg of sebum)
Control
period
Treatment periods
1st 3
weeks
2nd 3
weeks
3rd 3
weeks
All
treat-
ment
values
1
2
3
Mean
.55
.54
.61
.57
.61
.53
.61
.58
.47
.53
.67
.56
.58
.64
.74
.65
.55
.58
.68
.60
there was an inconsistent decrease in free acid-
ity. By contrast, the decrease in titratable acid-
ity observed in subject 13, which was more evi-
dent with the 4-gram dose, was maintained
throughout the treatment period. The titratable
acidity did not decrease in any of the other
subjects.
Sulfadimethoxine Three of the subjects
treated with sulfisoxazole were at a later date
administered 0.5 gm of sulfadimethoxine (Ma-
dribon®) daily (Table V). None showed any
essential change in free acidity during the pe-
riods of drug administration.
TABLE VI
Per cent decrease in titratable acidity during
administration of various antibacterial agents
Potassium phenoxy-
methyl penicillin
600,0C0 units/day
1,200,000 units/day
2,400,000 units/day
Erythromycin esto-
late, 1 gm/day
Demethyichlortetra-
cycline hydrochlo-
ride, 600 mg/day
Sulfisoxazole
2 gm/day
4 gm/day
Sulfadimethoxine, 0.5
gm/day
Tetracycline hydro-
chloride,* 1 gm/
DISCUSSION
As can be seen from Table VI, only erythro-
mycin and demethyichiortetracycline caused a
decrease in the titratable acidity of surface
lipid throughout the treatment period, similar
to that previously observed with tetracycline.
TABLE V
Titratable acidity of sebum during the
administration of sulfadimethoxine,
0.5 gm daily
Drug 1st 3weeks
None
None
None
23.1%
2nd 3
weeks
None
None
6.7%
29.2%
27.6% 53.3%
3rd 3
weeks
None
None
18.7%
27.7%
46.7%
None
None
None
31.0%
12.2%
None
None
19.0%
4.1%
None
1.8%
23.8%
day
* From Freinkel et al. (2).
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While there is not enough data for statistical
analysis, we tentatively consider the consistent
drop seen with these three agents to be signifi-
cant. It would appear that demethylchlortetra-
cycline was the most effective of the drugs
tested, but the sample sizes were too small to
permit any definite conclusion. The drop ob-
served with the highest dose of penicillin is the
reflection of a fall in free acidity observed in
one patient.
Several subjects received different drugs at
different times. Comparison of the effects result-
ing from the separate administration of more
than one drug in any one individual indicates
that only the broad-spectrum antibiotics will
regularly decrease the concentration of the free
acidity of sebum. Several individual examples
may be cited: (1) cases 1 and 3, who had pre-
viously shown a decrease in titratable acidity
with tetracycline, failed to show any change
with penicillin, sulfisoxazole or sulfadimethoxine;
(2) case 14, in whom a reduction in free acidity
occurred during tetracycline administration, did
not show any change with sulfisoxazole or
sulfadimethoxine; (3) cases 4 and 5 demon-
strated a decrease in titratable acidity with
demethylchlortetracycline but not with peni-
cillin; and (4) case 6 showed an effect from
erythromycin but not with penicillin. Case 2 is
also worth mentioning in that he failed to re-
spond to any of the agents administered includ-
ing tetracycline and demethylchlortetracycline.
The mechanism by which broad-spectrum
antibiotics produce the decrease in free acidity
of surface sebum is uncertain. Goltz and
Kjartansson (4) have demonstrated a reduction
in aerobic and anaerobic bacterial flora of hu-
man subjects administered tetracycline orally.
Thus, the most plausible explanation is that the
antibiotics inhibit bacterial reproduction and in
this way suppress free fatty acid formation.
Sebum, as freshly formed by the sebaceous
glands, contains little if any free fatty acid (5)
but when recovered from the skin surface,
roughly one-third to one-half of the fatty acids
are in the unesterified or free form (6). Lipase
activity has been demonstrated in the follicular
canal by histochemical technics (5, 7), and the
in vitro incubation of comedones with olive oil
results in free fatty acid liberation (8). How-
ever, the stimulus for fatty acid ester breakdown
is not clearly evident. The anaerobic diphthe-
roid, Corynebacterium acnes, is found in abun-
dance in the sebaceous follicles and has been re-
ported to possess lipolytie activity in vitro (9).
Since Corynebacterium acnes has been shown to
be sensitive in vitro to the broad-spectrum anti-
biotics but not to sulfonamides (10), these ob-
servations correlate well with the findings in the
present study of responses to the broad-spec-
trum antibiotics and to sulfonamides. However,
Corynebacterium acnes is also very sensitive to
penicillin in vitro (10). Failure to observe
changes in titratable acidity of sebum on peni-
cillin administration remains unexplained and
suggests alternate mechanisms for the effect of
the broad-spectrum antibiotics. Thus, suppres-
sion of free acidity may be unrelated to an
antibiotic effect and instead involve direct inter-
ference of cellular activity—for example, tetra-
cyclines have been shown to be selectively local-
ized in mitochondria (11). There might also be
differences among antibiotics in their ability to
penetrate into the follicular site. Information in
this regard is lacking at present.
SUMMARY
The effect of various antibiotics and ulfona-
mides on the titratable acidity of surface sebum
in normal adult males has been investigated.
Erythromycin estolate and demethylehlortetra-
cycline hydrochloride were found to decrease the
free acidity of sebum. Potassium phenoxy-
methyl penicillin, sulfisoxazole and sulfadimeth-
oxine did not alter the free acidity.
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